School of Medicine
Showing 1-10 of 52 Results
Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly Interests Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
Assistant Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly Interests The Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
Linda Boxer, MD, PhD
Vice Dean of the School of Medicine and Stanley McCormick Memorial Professor in the School of Medicine
Current Research and Scholarly Interests Regulation of expression of oncogenes in normal and malignant hematologic cells.
Clinical Assistant Professor, Medicine - Hematology
Current Research and Scholarly Interests I aim to provide high quality care in a diverse patient practice. My clinic includes all types of hematologic disorders, ranging from anemia, clotting/bleeding disorders, and low blood counts to complex malignancies such as leukemia, myelodysplastic syndrome, myeloma, and lymphoma.
My research interests include the advancement of personalized genomic medicine and the development of targeted therapeutics for cancer therapy.
My goal is to combine the efficiency of a private office with the complex care expected of a tertiary institution like Stanford. I value your time and strive to maintain an on-schedule clinic.
Clinical Instructor, Medicine - Hematology
Current Research and Scholarly Interests I am interested in the characterization and therapeutic targeting of cancer stem cells in human malignancies. Specifically I have been investigating antibody-specific approaches to therapeutically target leukemic stem cells in acute myeloid leukemia as well as targeting of cancer cells in other hematologic malignancies. This work has led to the identification and development of a monoclonal antibody targeting the anti-phagocytic signal CD47 for the treatment of human malignancies.
Postdoctoral Research Fellow, Hematology
Current Research and Scholarly Interests Seek to understand the molecular mechanism by which human telomerase (hTERT) promoter mutations contribute to the biology of tumor cells.
Professor of Medicine (Hematology) at the Stanford University Medical Center
Current Research and Scholarly Interests My research integrates clinical care of patients with novel treatments for a variety of hematologic disorders. I see patients with a wide range of problems with a particular focus on chronic lymphocytic leukemia and multiple myeloma. I provide comprehensive consultative services as well as treatment for both the acute and chronic leukemias as well as non-malignant conditions such as clotting disorders and thrombocytopenia.